Checking Your Eye Health After Radiation Treatment for Eye Cancer

In Plain English

This study follows patients like you who have been treated with a special type of radiation therapy called stereotactic photon radiotherapy for uveal melanoma (eye cancer). The radiation is designed to kill cancer cells while sparing as much healthy eye tissue as possible. However, radiation can sometimes damage the blood vessels and nerves in the eye over time, which is why doctors want to carefully monitor your eye health. You'll come in for eye imaging appointments before your radiation treatment, and then again at 3, 6, 9, and 12 months after treatment. These appointments use several different types of eye imaging tools—think of them like taking different kinds of photographs and measurements of your eye to catch any changes early. The goal is to understand how often these side effects happen, how serious they are, and how to better protect patients' vision in the future.

What This Trial Does

The purpose of this study is to evaluate the incidence and severity of retinopathy and opticopathy one year after treatment with hypofractionated stereotactic photon radiotherapy due to uveal melanoma. Patients will be imaged before radiation, as well as 3, 6, 9 and 12 months after radiation using sonography funds photography, optical coherence tomography angiography, oximeter and microperimetry.

Who Can Join

Treatments